A new study found that opioids are commonly prescribed to patients with gout who seek treatment at emergency departments. In the study of 456 patients with acute gout discharged from emergency departments in Rhode Island, more than 28% received an opioid prescription. Of these, more than one-quarter of patients received 14 days or more of opioid prescriptions, longer than the natural course of a typical gout attack.
New research suggests that some respiratory symptoms may predict an earlier death in older adults. In the study of 2087 older Australians with 22 years of follow-up, shortness of breath predicted a shorter life expectancy irrespective of smoking status. Cough in former smokers and wheeze in current smokers predicted shorter life expectancy.
Maternal primary cytomegalovirus (CMV) infection in the first trimester raises the risk of sensorineural hearing loss (SNHL) in children, researchers say. They assessed the incidence and risk factors for SNHL in 157 children with congenital CMV (cCMV) participating in a prospective 22-year study that included virus screening (saliva or urine CMV) within 5 days of birth.
A comprehensive, longitudinal study of patients with multiple sclerosis (MS) that followed patients from the time of their diagnosis for an average of five years, has found that while a commonly used imaging linear contrast agent, gadodiamide, does accumulate in the brain early in the disease, there is no discernible clinical impact.
A revised program for Insurer Blue Shield of California was created in collaboration with Solera Health. This program is designed to match members enrolled in Blue Shield's fully-insured employer-sponsored plans and also recommends digital therapeutic providers and mobile health apps. The new program also holds the wellness providers accountable for delivering results and quality of care.
A federal appeals court is giving a Florida dentist a chance to prove his before-and-after smile photos had enough originality to warrant copyright protection. The per curiam decision by the 11th U.S. Circuit Court of Appeals at Atlanta reversed a trial judge’s decision to toss the case.
A team from the University of Michigan reported findings, shows that the readmission penalty program may be spinning its wheels more than it's slowing the spinning of the revolving hospital door. The study reported that readmission rate for these patients started showing a drop in the rates after they were announced to be a part of Affordable Care Act in 2010.
Researchers have found a protein that could help reduce the aggregation of toxic proteins in the brain — a hallmark of Parkinson's disease. But does their discovery offer fresh hope or just "a Band-Aid?". The study has identified a protein able to reduce the aggregation of misfolded alpha-synuclein. The new research has focused on the therapeutic potential of a protein called "HYPE," which, the investigators explain, is the only Fic protein present in humans.
The U.S. Food and Drug Administration today approved Soliris (eculizumab) injection for intravenous use for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive. NMOSD is an autoimmune disease of the central nervous system that mainly affects the optic nerves and spinal cord. Soliris provides the first FDA-approved treatment for neuromyelitis optica spectrum disorder, a debilitating disease that profoundly impacts patients’ lives.
Women with ovarian cancer who have undergone four or more rounds of chemotherapy typically haven't had much hope that another treatment option will lengthen their lives in a meaningful way. However, a new research study shows tremendous promise for a drug called niraparib to extend life when all options have been exhausted.